Bapineuzumab - CISMeF

Preferred Label : Bapineuzumab;

NCIt synonyms : AAB-001; Humanized 3D-6 Monoclonal Antibody; Anti-human beta-amyloid Monoclonal Antibody 3D-6;

NCIt definition : A humanized monoclonal antibody (IgG1) raised against amyloid beta peptides with Alzheimer disease treatment application. Bapineuzumab recognizes and binds the N-terminal amino acids 1-5 of the amyloid beta peptide, and may be used in a passive immunotherapy treatment.;

UNII : NC11WKO35D;

CAS number : 648895-38-9;

Détails

Origin ID

C79569;

UMLS CUI

C2698328;

Automatic exact mappings (from CISMeF team)
- AAB-001 [MeSH concept]
Currated CISMeF NLP mapping
- Bapineuzumab [SMS substance]
- bapineuzumab [MeSH concept]
- bapineuzumab [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- bapineuzumab [MeSH Supplementary Concept]
- bapineuzumab [MeSH concept]
chemical_or_drug_has_mechanism_of_action
- Antigen Binding [NCIt concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients